Detailed answers about BLOOD CANCER UK RESEARCH, including incorporation, status, business activity, and accounts information.
When was BLOOD CANCER UK RESEARCH founded?
BLOOD CANCER UK RESEARCH was officially incorporated on 17 October 1962 and is registered under company number 00738089. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is BLOOD CANCER UK RESEARCH?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of BLOOD CANCER UK RESEARCH?
BLOOD CANCER UK RESEARCH's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does BLOOD CANCER UK RESEARCH do?
BLOOD CANCER UK RESEARCH operates in the following sectors: 72190 - Other research and experimental development on natural sciences and engineering, 86900 - Other human health activities. These SIC codes provide insight into the company's business activities and industry focus.
What is BLOOD CANCER UK RESEARCH's registered address?
The registered office address of BLOOD CANCER UK RESEARCH is 5-11 THEOBALDS ROAD, LONDON, ENGLAND, WC1X 8SH. This is the official address filed with Companies House for legal and statutory correspondence.
Is BLOOD CANCER UK RESEARCH financially stable?
The most recent accounts for BLOOD CANCER UK RESEARCH were made up to 31 March 2025, filed as GROUP. Next accounts are due by 31 December 2026.
Does BLOOD CANCER UK RESEARCH have any charges or mortgages?
BLOOD CANCER UK RESEARCH has 1 registered charge, of which 0 are outstanding, 1 satisfied, and 0 part satisfied. Charges are typically registered when a company uses its assets as security for borrowing.
Has BLOOD CANCER UK RESEARCH changed its name?
Yes, BLOOD CANCER UK RESEARCH has had 3 previous names: BLOODWISE (changed 3 April 2024), LEUKAEMIA & LYMPHOMA RESEARCH (changed 2 April 2015), LEUKAEMIA RESEARCH FUND LIMITED (changed 10 December 2009).